Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

InSite Vision Inc

+ Add to Watchlist

INSV:US

0.1500 USD 0.0001 0.07%

As of 20:10:04 ET on 05/04/2015.

Snapshot for InSite Vision Inc (INSV)

Open: 0.1352 Day's Range: 0.1352 - 0.1500 Volume: 1,211
Previous Close: 0.1499 52wk Range: 0.1000 - 0.3600 1-Yr Rtn: -14.29%

Stock Chart for INSV

No chart data available.
  • INSV:US 0.1500
  • 1D
  • 1M
  • 1Y
0.1499
Interactive INSV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for INSV

Current P/E Ratio (ttm) 6.5217
Estimated P/E(12/2015) -
Relative P/E vs. SPX 0.3511
Earnings Per Share (USD) (ttm) 0.0230
Est. EPS (USD) (12/2015) -0.0800
Est. PEG Ratio -
Market Cap (M USD) 19.79
Shares Outstanding (M) 131.95
30 Day Average Volume 51,618
Price/Book (mrq) -
Price/Sale (ttm) 2.4096
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for INSV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for INSV

InSite Vision Incorporated develops ophthalmic pharmaceutical products based on its DuraSite drug delivery technology. The Company also develops genetically based tools for the diagnosis and prognosis of glaucoma. InSite's products are intended to address a broad spectrum of ocular indications, including glaucoma, inflammation, and infection.

Timothy M RuaneChief Executive OfficerLouis C DrapeauVP/CFO
Kamran HosseiniVP:Clinical & RegulatoryLyle M BowmanVP:Development/Secretary
More Company Profile & Key Executives for INSV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil